WHO ICTRP trial
Japanese POEMS Syndrome with Thalidomide Trial
JPRN-jRCT1091220046 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-jRCT1091220046 |
|---|---|
| Public title | Japanese POEMS Syndrome with Thalidomide Trial |
| Scientific title | Thalidomide Treatment for Crow-Fukase (POEMS) Syndrome: A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial with an Extension Phase to Evaluate the Long-term Safety - J - POST Trial |
| Primary sponsor | J-POST Clinical Trial Office |
| Secondary sponsors | Hokkaido University, Hokkaido Medical Center, Tohoku University, Chiba University, Saitama Medical University, Niigata University, Shinshu University, Nagoya University, Kinki University, Kobe City… |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | 2-3 |
| Countries | Japan |
| Conditions | Crow-Fukase (POEMS)syndrome |
| Interventions | Intervention type:DRUG Name of intervention:FPF 300 (thalidomide) Dose form / Japanese Medical Device Nomenclature:CAPSULE Route of administration / Site of application:ORAL Dose per administration:100 100-300 mg Dosing frequency /… |
| Registration date | Jun 9, 2010 |
| Target size | 24 |
| Secondary IDs | JMA-IIA00046 |
| Registry page | jrct.niph.go.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: